ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2019. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $84,000 | -84.4% | 138,666 | -75.1% | 0.00% | – |
Q3 2021 | $540,000 | +3076.5% | 557,157 | +3449.4% | 0.00% | – |
Q2 2021 | $17,000 | -95.6% | 15,697 | -96.2% | 0.00% | – |
Q1 2021 | $390,000 | +2337.5% | 414,540 | +1970.9% | 0.00% | – |
Q3 2020 | $16,000 | -51.5% | 20,017 | -67.0% | 0.00% | – |
Q2 2020 | $33,000 | +73.7% | 60,632 | +11.7% | 0.00% | – |
Q1 2020 | $19,000 | 0.0% | 54,273 | +94.6% | 0.00% | – |
Q3 2019 | $19,000 | -90.2% | 27,885 | -69.7% | 0.00% | – |
Q1 2019 | $194,000 | +28.5% | 92,126 | +113.5% | 0.00% | – |
Q1 2018 | $151,000 | -20.5% | 43,150 | +0.1% | 0.00% | – |
Q4 2017 | $190,000 | +25.0% | 43,117 | +48.2% | 0.00% | – |
Q3 2017 | $152,000 | +149.2% | 29,100 | +149.7% | 0.00% | – |
Q2 2017 | $61,000 | -26.5% | 11,654 | -52.1% | 0.00% | – |
Q3 2016 | $83,000 | – | 24,324 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|